Basic Fibroblast Growth Factor Radioprotects Bone Marrow and not RIF1 Tumor

References

• Haimovitz-Friedman A, Vlodavsky I, Chaudhuri A, Witte L, Fuks Z. Autocrine effects of fibroblast growth factor in repair of radiation damage in endothelial cells. Cancer Res 1991; 51: 2552–8
   PubMed Web of Science ®Google Scholar
• Fuks Z, Persaud R S, Alfieri A, et al. Basic fibroblast growth factor protects endothelial cells against radiation-induced programmed cell death in vitro and in vivo. Cancer Res 1994; 54: 2582–90
   PubMed Web of Science ®Google Scholar
• Bruno E, Cooper R J, Wilson E L, Gabrilove J L, Hoffman R. Basic fibroblast growth factor promotes the proliferation of human megakaryocyte progenitor cells. Blood 1993; 82: 430–5
   PubMedGoogle Scholar
• Gallicchio V S, Hughes N K, Hulette B C, DellaPuca R, Noblitt L. Basic fibroblast growth factor (bFGF) induces early- (CFU-s) and late-stage hematopoietic progenitor cell colony formation (CFU-gm, CFU-meg, and BFU-e) by synergizing with GM-CSF, Meg-CSF, and erythropoietin, and is a radioprotective agent in vitro. Int J Cell Cloning 1991; 9: 220–32
   PubMedGoogle Scholar
• Gabbianelli M, Sargiacomo M, Pelosi E, Testa U, Isacchi G, Peschle C. ‘Pure’ human hematopoietic progenitors: permissible action of basic fibroblast growth factor. Science 1990; 249: 1561–4
   PubMed Web of Science ®Google Scholar
• Bikfalvi A, Han Z C, Fuhrmann G. Interaction of fibroblastic growth factor (FGF) with megakaryocytopoiesis and demonstration of FGF receptor expression in megakaryocytes and megakaryocytic-like cells. Blood 1992; 80: 1905–13
   PubMed Web of Science ®Google Scholar
• Hannocks M J, Oliver L, Gabrilove J L, Wilson E L. Regulation of proteolytic activity in human bone marrow stromal cells by basic fibroblast growth factor, interleukin-1, and transforming growth factor β. Blood 1992; 79: 1178–84
   PubMedGoogle Scholar
• Wilson E L, Rifkin D B, Kelly F, Hannocks M J, Gabrilove J L. Basic fibroblast growth factor stimulates myelopoiesis in long term human bone marrow cultures. Blood 1991; 77: 945–60
   Google Scholar
• Noff D, Pitaru S, Savion N. Basic fibroblast growth factor enhances the capacity of bone marrow cells to form bone-like nodules in vitro. FEBS Lett 1989; 250: 619–21
   PubMed Web of Science ®Google Scholar
• Liebmann J, DeLuca A M, Epstein A, Steinberg S M, Morstyn G, Mitchell J B. Protection from lethal irradiation by combination of stem cell factor and Tempol. Radiat Res 1994; 137: 400–4
   PubMedGoogle Scholar
• Brown J M, Yu N Y, Workman P. Pharmacodynamic considerations in testing hypoxic cell radiosensitizers in mouse tumours. Br J Cancer 1979; 39: 310–5
   PubMed Web of Science ®Google Scholar
• Thames H D, Suit H D. Tumor radioresponsiveness versus fractionation sensitivity. Int J Radiat Oncol Biol Phys 1986; 12: 687–91
   PubMed Web of Science ®Google Scholar
• Thames H D, Schultheiss T E, Hendry J H, Tucker S L, Dubray B M, Brock W A. Can modest escalations of dose be detected as increased tumor control?. Int J Radiat Oncol Biol Phys 1992; 22: 241–6
   PubMed Web of Science ®Google Scholar
• Fowler J F, Chappell R. Steepness of dose-response curve for larynx cancer. Radiother Oncol 1994, (In press)
   PubMedGoogle Scholar
• Withers H R. From bedside to bench and back. Radiation research: A twentieth-century perspective, W C Dewey, M Edington, R JM Fry, E J Hall, G F Whitmore. Academic Press, Inc., San Diego 1992; Volume II: 30–70
   Google Scholar
• Fuks Z, Weichselbaum R R. Radiation tolerance and the new biology: growth factor involvement an the radiation injury to the lung. Int J Radiat Oncol Biol Phys 1992; 24: 183–4
   PubMedGoogle Scholar
• Marks L B, Spencer D P, Bentel G C, et al. The utility of SPECT lung perfusion scans in minimizing and assessing the physiologic consequences of thoracic irradiation. Int J Radiat Oncol Biol Phys 1993; 26: 659–68
   PubMed Web of Science ®Google Scholar
• Anscher M S, Murase T, Prescott D M, et al. Changes in plasma TGFβ levels during pulmonary radiotherapy as a predictor of the risk of developing radiation pneumonitis. Int J Radiat Oncol Biol Phys 1994; 30: 671–6
   PubMed Web of Science ®Google Scholar
• Grant S, Traylor R, Pettit G R, Lin P S. The macrocyclic lactone protein kinase C activator, bryostatin 1, either alone, or in conjunction with rmGM-CSF, protects Balb/c and C3H/HeN mice from the lethal in vivo effects of ionizing radiation. Cell 1994; 83: 663–7
   Google Scholar
• Allalunis-Turner M J, Walden T L, Sawich C. Induction of marrow hypoxia by radioprotective agents. Radiat Res 1989; 118: 581–6
   PubMedGoogle Scholar
• Okunieff P. Interactions between ascorbic acid and the radiation of bone marrow, skin, and of tumor. Am J Clin Nutr 1991; 54(Suppl 6)12815–35
   Google Scholar